HP

HealthInvest Partners Portfolio holdings

AUM $313M
1-Year Est. Return 48.65%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+48.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$313M
AUM Growth
+$286M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$8.4M
2
+$6.96M
3
+$6.86M
4
INSM icon
Insmed
INSM
+$5.09M
5
ABBV icon
AbbVie
ABBV
+$3.66M

Top Sells

1
+$5.84M
2
+$3.33M
3
+$2.19M
4
KRYS icon
Krystal Biotech
KRYS
+$1.75M
5
COR icon
Cencora
COR
+$1.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
26
Cardinal Health
CAH
$51.1B
$4.82M 1.54%
23,470
-6,827
ABVX
27
Abivax
ABVX
$9.13B
$4.26M 1.36%
+31,590
CELC icon
28
Celcuity
CELC
$5.29B
$4.17M 1.33%
41,831
+4,674
IRON icon
29
Disc Medicine
IRON
$2.29B
$3.81M 1.22%
47,967
+2,277
IDYA icon
30
IDEAYA Biosciences
IDYA
$2.91B
$3.37M 1.07%
+97,438
UNH icon
31
UnitedHealth
UNH
$256B
$3.19M 1.02%
14,636
+909
CMPX icon
32
Compass Therapeutics
CMPX
$923M
$3.14M 1%
+584,332
SLNO icon
33
Soleno Therapeutics
SLNO
$1.74B
$2.9M 0.93%
62,735
+2,579
ACLX icon
34
Arcellx
ACLX
$6.69B
$2.72M 0.87%
41,717
+15,985
DXCM icon
35
DexCom
DXCM
$24.7B
$2.64M 0.84%
39,722
-11,150
AUTL
36
Autolus Therapeutics
AUTL
$383M
$2.33M 0.74%
1,169,634
BCAX
37
Bicara Therapeutics
BCAX
$1.24B
$1.87M 0.6%
111,363
-92,392
CRBP icon
38
Corbus Pharmaceuticals
CRBP
$165M
$873K 0.28%
107,255
-68,327
PYXS icon
39
Pyxis Oncology
PYXS
$95.9M
$710K 0.23%
+617,245
EW icon
40
Edwards Lifesciences
EW
$47.5B
– –
-65,659
HRMY icon
41
Harmony Biosciences
HRMY
$1.6B
– –
-92,074
JANX icon
42
Janux Therapeutics
JANX
$826M
– –
-49,820
MREO
43
Mereo BioPharma
MREO
$61.4M
– –
-764,901
MRUS
44
DELISTED
Merus
MRUS
– –
-47,999
RNAM
45
DELISTED
Avidity Biosciences
RNAM
– –
-51,978
SMMT icon
46
Summit Therapeutics
SMMT
$12.5B
– –
-92,737
1
2